MXiPr, a Dissociatives, and 4-MeO-PCP, a Dissociatives, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Dissociativess, meaning they share a common pharmacological foundation. They share 39 documented effects in common, with 14 effects unique to MXiPr and 5 unique to 4-MeO-PCP. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Effects | 53 documented | 44 documented |
| Interaction | Caution | |
| Level | MXiPr | 4-MeO-PCP |
|---|---|---|
| Threshold | 5 mg | 15 mg |
| Light | 10–20 mg | 30–75 mg |
| Common | 20–40 mg | 75–150 mg |
| Strong | 40–60 mg | — mg |
| Heavy | 60 mg | 150 mg |
| Level | MXiPr | 4-MeO-PCP |
|---|---|---|
| Threshold | 5 mg | 25 mg |
| Light | 10–20 mg | 75–100 mg |
| Common | 20–40 mg | 100–170 mg |
| Strong | 40–60 mg | 170–250 mg |
| Heavy | 60 mg | 250 mg |
MXiPr
4-MeO-PCP
MXiPr
4-MeO-PCP
Compounding dissociative effects can cause confusion, mania, and loss of motor control